Keeping vaccines safe – New podcast on COVID-19 vaccine surveillance

Signal detection / 29 June 2021

Photo: iStock

UMC experts discuss how real-time vaccine surveillance works during a pandemic and the role of VigiBase in helping to ensure public safety.


With COVID-19 vaccinations rolling at full speed in many countries, there’s a lot of talk about vaccine safety monitoring. But what exactly does that mean and how should we be interpreting data on side effects? Uppsala Monitoring Centre’s Helena Sköld and Annette Rudolph walk us through the basics of vaccine pharmacovigilance.

Helena Sköld and Annette Rudolph. Photos: UMC

Subscribe by visiting the Drug Safety Matters website or listen in right here:

Related Articles

How VigiFlow is helping to keep the wheel of pharmacovigilance turning in South Africa

Safety monitoring of orphan drugs: The SFDA experience

Unmasking data in the COVID-19 vaccine era – New podcast episode

You may also like

Unmasking data in the COVID-19 vaccine era – New podcast episode

What are the implications for signal detection when new approaches to reporting create greater data streams than have ever been present for older medicinal products?

Signal detection / 30 January 2023

Safety monitoring of orphan drugs: The SFDA experience

The safety of orphan drugs is hard to monitor as they target rare diseases afflicting small patient populations. However, an initiative led by the SFDA aims to improve this.

Signal detection / 12 August 2024

How VigiFlow is helping to keep the wheel of pharmacovigilance turning in South Africa

South Africa’s pharmacovigilance system has been evolving for over a decade with UMC’s data management system supporting them every step of the way.

Signal detection / 02 September 2024